At today's Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) in Boston, Angela Lorts, MD, MBA, issued an urgent call for improved ...
10 April, 2024, Prague, Czech Republic—The same technology that enables a bullet train to travel at speeds up to 200 mph without touching its rails now keeps a failing heart pumping—and in the near ...
HOUSTON--(BUSINESS WIRE)--Saranas, Inc. announced today that it has reached the midpoint for enrollment in SAFE-MCS, a multi-center, single arm, open-label clinical trial evaluating the safety of ...
Patients with severe heart failure or cardiogenic shock often need mechanical circulatory support (MCS) devices but deciding when to safely wean them off remains a challenge. Researchers from Shinshu ...
Abbott Laboratories ABT recently confirmed that it has adequate capacity and supply to support the expanded use of HeartMate3 heart pump to meet the rising demand for mechanical circulatory support ...
The same technology that enables a bullet train to travel at speeds up to 200 mph without touching its rails now keeps a failing heart pumping - and in the near future, it will do so via a wireless ...
PARIS – The High Authority for Health (HAS) in France recently published a 165-page report on use over 10 years of long term mechanical circulatory assist devices (MCS). HAS conducted this ...
A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such ...
HOUSTON--(BUSINESS WIRE)--Saranas, Inc. announced today that it has completed enrollment in SAFE-MCS, a multi-center, single arm, open-label clinical trial evaluating the safety of complex high-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results